Charles R. Eyler, SEE REMARKS at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 820 shares at $33.24 ($27K) on 2017-01-20, disclosed to the SEC on 2017-01-24.
Scheduled sale ($27k) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PBYI | SELL | 2019-01-04 | $25K | — | Filing → |
| PBYI | SELL | 2018-12-04 | $28K | — | Filing → |
| PBYI | SELL | 2018-07-24 | $32K | — | Filing → |